Clinical trials

  • EGANELISIB for Acute myeloid leukemia (relapsed/refractory) | High-risk myelodysplastic syndromes (relapsed/refractory)
  • ICEF15 (autologous Skeletal Derived Muscle Cells - aSMDC) for Fecal incontinence
  • Dapagliflozin for Chronic kidney disease (CKD) | Chronic kidney disease stage 3 | Chronic kidney disease stage 4
  • Durvalumab for Solid tumours|Solid tumours with homologous recombination repair (HRR) gene mutation
  • MIBAVADEMAB for Monogenic obesity|Congenital leptin deficiency
  • Cagrilintide for Obesity | Postmenopausal state
  • DRY EXTRACT FROM PSILOCYBE CUBENSIS (15-25:1), EXTRACTION SOLVENT: METHANOL for Severe Alcohol Use Disorder
  • Fluconazole for Invasive fungal infection
  • RITUXIMAB for ANCA-associated vasculitis (AAV)
  • ac-ala-gly-ser-cys(1)-tyr-cys(2)-ser-gly-pro-pro-arg-phe-glu-cys(2)-trp-cys(1)-tyr-glu-thr-glu-gly-thr-gly-gly-gly-lys(unk)-nh2 conjugated to cy5 dye for Penile squamous cell carcinoma | Tongue squamous cell carcinoma
  • Rondaptivon pegol for Von Willebrand disease type 2B
  • L-lysine acetate; L-tryptophan; L-histidine; L-threonine; L-tyrosine; keto-isoleucine calcium; keto-leucine calcium; keto-valine calcium; hydroxi-methionine calcium; alpha-ketophenylalanine calcium for Protein-energy wasting in nephrotic syndrome